Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | Sr. VP, Corp. Affairs & Comm. | January 27, 2009 | January 29, 2009 |
| Guardant Health, Inc.GH · Entity 3238 | Director | October 12, 2026 | October 13, 2026 |
| HMS HOLDINGS CORPHMSY · Entity 140668 | Director | September 30, 2017 | October 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date January 27, 2009 · Filed January 29, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2010-02-01 | Direct | 17,084 |
Reported balance
After 2009-01-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2009-01-27 · Grant · Acquired 17,084 · Balance 17,084 F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Guardant Health, Inc.
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 962 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Exercise / conversion · Acquired 137 · Balance 962 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,816 |
Reported balance
After 2026-10-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-12 · Exercise / conversion · Disposed 137 · Balance 4,816 F1: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.
F2: Not applicable for Restricted Stock Units.
HMS HOLDINGS CORP
Report date September 30, 2017 · Filed October 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,034 |
Reported balance
After 2017-09-30 transaction · row 1
1 source rowRow 1 · 2017-09-30 · Grant · Acquired 957 · Balance 17,034 F1: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 21:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001402256-26-000008 · wk-form4_1791925851.xml · derivative · entry 2 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,816 Underlying: Common Stock · 137 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 21:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001402256-26-000008 · wk-form4_1791925851.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 17, 2026 21:09 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 826 | $175.00 | $144,550.00 |
DisclosureSEC source: 0001402256-26-000006 · wk-form4_1789679393.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 825 Read SEC document |
| September 12, 2026 Filed Sep 14, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,651 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001402256-26-000004 · wk-form4_1789423947.xml · derivative · entry 2 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,953 Underlying: Common Stock · 1,651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 12, 2026 Filed Sep 14, 2026 22:12 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001402256-26-000004 · wk-form4_1789423947.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:50 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 2,711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001402256-26-000002 · wk-form4_1782165027.xml · derivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,711 Underlying: Common Stock · 2,711 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 12, 2025 Filed Sep 26, 2025 21:04 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 6,604 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001402256-25-000008 · wk-form4_1758920693.xml · derivative · entry 2 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,604 Underlying: Common Stock · 6,604 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of September 12, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 12, 2025 Filed Sep 26, 2025 21:04 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 10,532 | $0.00 Strike: $54.90 | $0.00 |
DisclosureSEC source: 0001402256-25-000008 · wk-form4_1758920693.xml · derivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,532 Underlying: Common Stock · 10,532 shares Expires 2035-09-12 F1 · derivative.exercise_date: The stock option was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of September 12, 2025 and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 20:50 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 957 | $19.86 | $19,006.02 |
DisclosureSEC source: 0001225208-17-015604 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,034 F1 · shares: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 22:04 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 6,743 | $0.00 Strike: $17.45 | $0.00 |
DisclosureSEC source: 0001225208-17-014255 · doc4.xml · derivative · entry 2 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,743 Underlying: Common Stock · 6,743 shares Expires 2027-08-21 F2 · derivative.exercise_date: The option vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| August 21, 2017 Filed Aug 22, 2017 22:04 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 6,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014255 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,077 F1 · shares: Represents restricted stock units (RSUs) payable in an equal number of shares of the Issuer's common stock. The RSUs vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2018 annual meeting of stockholders. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:16 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 811 | $18.50 | $15,003.50 |
DisclosureSEC source: 0001225208-17-012184 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,334 F1 · shares: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:44 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 738 | $20.33 | $15,003.54 |
DisclosureSEC source: 0001225208-17-007545 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,523 F1 · shares: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 22:08 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 728 | $18.16 | $13,220.48 |
DisclosureSEC source: 0001225208-17-000125 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,785 F1 · shares: Represents deferred stock units 1) acquired under the Issuer's Director Deferred Compensation Plan in lieu of all or a portion of the Reporting Person's quarterly cash retainer fees for Board services and 2) payable in shares of the Issuer's common stock. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 23:19 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantNonqualified Stock Option (Right to Buy) · Derivative | 7,057 | $0.00 Strike: $16.54 | $0.00 |
DisclosureSEC source: 0001225208-16-041720 · doc4.xml · derivative · entry 2 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 Underlying: Common Stock · 7,057 shares Expires 2026-11-11 F2 · derivative.exercise_date: The option vests 25% a quarter over four calendar quarters, with the first 25% vesting on December 31 of the year of grant and 25% vesting on the last day of each subsequent quarter. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 23:19 UTC | HMS HOLDINGS CORP HMSY · Entity 140668 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-041720 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 F1 · shares: Represents restricted stock units (RSUs) payable in an equal number of shares of the Issuer's common stock. The RSUs vest 25% a quarter over four calendar quarters, with the first 25% vesting on December 31 of the year of grant and 25% vesting on the last day of each subsequent quarter. Read SEC document |
| January 27, 2009 Filed Jan 29, 2009 22:32 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 17,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-005393 · doc4.xml · derivative · entry 1 Azar Alex M II · CIK 0001402256 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,084 Underlying: Common Stock · 17,084 shares Expires 2010-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| July 02, 2007 Filed Jul 3, 2007 15:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 5,000 | $56.73 | $283,650.00 |
DisclosureSEC source: 0001209191-07-040320 · doc4.xml · nonDerivative · entry 1 Azar Alex M II · CIK 0001402256 · Sr. VP, Corp. Affairs & Comm. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.